Novo Nordisk sues Hims & Hers over ‘knock-off Wegovy’

Pharmaceutical giant Novo Nordisk announced Monday it is suing telemedicine platform Hims & Hers for allegedly “deceiving patients and putting their health at risk” by selling compounded versions of its blockbuster GLP-1 medication semaglutide. Novo Nordisk alleges in its lawsuit that Hims & Hers has infringed on its patent by selling compounded Ozempic and Wegovy…

Novo Nordisk sues Hims & Hers over ‘knock-off Wegovy’

FDA reviewing food preservative BHA

AMA launching its own vaccine safety, effectiveness review system

AMA launching its own vaccine safety, effectiveness review system

Americans die younger in states with conservative policies: study

US bans foreign travelers from Ebola-impacted nations

Those at risk for severe COVID-19 often least likely to get monoclonal antibodies

HHS withdraws amended vaccine advisory panel charter

GLP-1 drugs linked to boosting testosterone, sperm count in men

Health Care — Draft Supreme Court opinion sets off uproar

UN calls reproductive rights ‘foundation’ of equality for women and girls

57 percent in new poll want Supreme Court to support abortion rights

GLP-1 drugs linked to boosting testosterone, sperm count in men

New drug combo may preserve muscle during weight loss

GLP-1 drug tirzepatide may boost calorie-burning brown fat

US’s fertility rate has declined since 2007. It’s even worse in these states

Recent News

GLP-1 drugs linked to boosting testosterone, sperm count in men

New drug combo may preserve muscle during weight loss

GLP-1 drug tirzepatide may boost calorie-burning brown fat

US’s fertility rate has declined since 2007. It’s even worse in these states